Risk and clinical predictors of osteoporotic fracture in East Asian patients with chronic obstructive pulmonary disease: a population-based cohort study

Ping-Hsueh Lee, Victor C Kok, Po-Liang Chou, Ming-Chang Ku, Yu-Ching Chen, Jorng-Tzong Horng, Ping-Hsueh Lee, Victor C Kok, Po-Liang Chou, Ming-Chang Ku, Yu-Ching Chen, Jorng-Tzong Horng

Abstract

Introduction: Osteoporosis is becoming an impending epidemic in the Asia-Pacific region. The association between risk of osteoporotic fracture (OTPF) and chronic obstructive pulmonary disease (COPD) in East Asian patients is yet to be fully examined. We conducted a nationwide population-based retrospective cohort study of 98,700 patients aged ≥50 years with or without COPD using a national administrative claims dataset.

Materials and methods: The patients were divided into COPD and comparison groups comprising 19,740 and 78,960 patients, respectively. The groups were 1 to 4 matched for age, gender, index date, diabetes mellitus, pre-existing osteoporosis and chronic kidney disease. Information such as the geographic area where southern part represented more sunshine exposure, smoking-related diagnoses, alcohol use disorder, whether there was regular use of inhaled corticosteroids and oral corticosteroids, vitamin D prescriptions, Charlson-Deyo comorbidity index score, and other relevant medical comorbidities were extracted for analysis. They were followed up until OTPF or the end of the year 2013. The outcome measure was an osteoporotic vertebral fracture and other long-bone fractures. A multivariate Cox model was constructed to derive adjusted hazard ratios (aHR) for OTPF with corresponding 95% confidence intervals (CI) after controlling for age, sex, insurance premium category, vitamin D prescription, osteoporosis, and coronary heart disease (CHD). Kaplan-Meier curves of the probability of OTPF-free survival for each cohort were compared using the log-rank test. Patients with OTPF during the first follow-up year were excluded from the overall risk calculation. Contributing factors to the increased risk of OTPF in COPD patients were examined in a sensitivity analysis.

Results: After a total follow-up of 68,743 patient-years for the COPD group and 278,051 patient-years for the matched comparison group, the HR for OTPF was 1.24 (95% CI [1.02-1.51]; P = 0.0322) in COPD patients. The aHR was increased by 30% for vertebral OTPF (aHR = 1.297, 95% CI [1.020-1.649]; P = 0.0339). Differential lag time sensitivity analysis revealed a progressively elevated risk up to 8-fold increase in women (aHR = 8.0 (95% CI [1.81-35.4]; P < 0.01)) during the fifth follow-up year. COPD patients with pre-existing osteoporosis or given vitamin D prescription harbor a sustained increased risk up to the 5th (aHR, 4.1; 95% CI [1.61-10.35]) and third (aHR, 2.97; 95% CI [1.48-5.97]) follow-up year, respectively.

Conclusions: Our nationwide population-based cohort study demonstrates that East Asian COPD patients aged 50 and beyond do harbor a modestly increased risk for osteoporotic vertebral fractures particularly for those who are female, have pre-existing osteoporosis or require vitamin D prescription.

Keywords: Asian; COPD; Longitudinal study; Osteoporosis; Osteoporotic fracture; Population-based study; Retrospective cohort study; Vertebral fracture; Vlinical predictors.

Conflict of interest statement

The authors declare there are no competing interests.

Figures

Figure 1. Consort diagram of the present…
Figure 1. Consort diagram of the present study flow.
Figure 2. Cumulative incidence curves of osteoporotic…
Figure 2. Cumulative incidence curves of osteoporotic fracture in COPD patients and non-COPD comparators matched for age, sex, index date, osteoporosis, diabetes mellitus and chronic kidney disease.
Figure 3. Cumulative incidence curves of osteoporotic…
Figure 3. Cumulative incidence curves of osteoporotic vertebral fracture in COPD patients and non-COPD comparators after multivariate adjustment.

References

    1. Abrahamsen B, Van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporosis International. 2009;20:1633–1650. doi: 10.1007/s00198-009-0920-3.
    1. Beauchamp MK, Janaudis-Ferreira T, Parreira V, Romano JM, Woon L, Goldstein RS, Brooks D. A randomized controlled trial of balance training during pulmonary rehabilitation for individuals with COPD. Chest. 2013;144:1803–1810. doi: 10.1378/chest.13-1093.
    1. Bian P, Li X, Ying Q, Chen J, Jin X, Yao J, Shou Z. Factors associated with low femoral neck bone mineral density in very elderly Chinese males. Archives of Gerontology and Geriatrics. 2015;61:484–488. doi: 10.1016/j.archger.2015.08.010.
    1. Biskobing DM. COPD and osteoporosis. Chest. 2002;121:609–620. doi: 10.1378/chest.121.2.609.
    1. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. Journal of Bone and Mineral Research. 2007;22:465–475. doi: 10.1359/jbmr.061113.
    1. Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporosis International. 2007;18:1319–1328. doi: 10.1007/s00198-007-0394-0.
    1. Chen SJ, Liao WC, Huang KH, Lin CL, Tsai WC, Kung PT, Chang KH, Kao CH. Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study. Qjm. 2015;108:633–640. doi: 10.1093/qjmed/hcv012.
    1. Choi YJ, Oh HJ, Kim DJ, Lee Y, Chung YS. The prevalence of osteoporosis in Korean adults aged 50 years or older and the higher diagnosis rates in women who were beneficiaries of a national screening program: the Korea National Health and Nutrition Examination Survey 2008-2009. Journal of Bone and Mineral Research. 2012;27:1879–1886. doi: 10.1002/jbmr.1635.
    1. Crisan AF, Oancea C, Timar B, Fira-Mladinescu O, Tudorache V. Balance impairment in patients with COPD. PLoS ONE. 2015;10:e2634. doi: 10.1371/journal.pone.0120573.
    1. Dam TT, Harrison S, Fink HA, Ramsdell J, Barrett-Connor E. Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma. Osteoporosis International. 2010;21:1341–1349. doi: 10.1007/s00198-009-1076-x.
    1. Dargent-Molina P, Favier F, Grandjean H, Baudoin C, Schott AM, Hausherr E, Meunier PJ, Breart G. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996;348:145–149. doi: 10.1016/S0140-6736(96)01440-7.
    1. Eisler J, Cornwall R, Strauss E, Koval K, Siu A, Gilbert M. Outcomes of elderly patients with nondisplaced femoral neck fractures. Clinical Orthopaedics and Related Research. 2002;399:52–58.
    1. Fife D, Barancik JI. Northeastern Ohio Trauma Study III: incidence of fractures. Annals of Emergency Medicine. 1985;14:244–248. doi: 10.1016/S0196-0644(85)80448-0.
    1. Graat-Verboom L, Smeenk FW, Van den Borne BE, Spruit MA, Jansen FH, Van Enschot JW, Wouters EF. Progression of osteoporosis in patients with COPD: a 3-year follow up study. Respiratory Medicine. 2012;106:861–870. doi: 10.1016/j.rmed.2011.12.020.
    1. Graat-Verboom L, Wouters EF, Smeenk FW, Van den Borne BE, Lunde R, Spruit MA. Current status of research on osteoporosis in COPD: a systematic review. European Respiratory Journal. 2009;34:209–218. doi: 10.1183/09031936.50130408.
    1. Harrison SL, Beauchamp MK, Sibley K, Araujo T, Romano J, Goldstein RS, Brooks D. Minimizing the evidence-practice gap - a prospective cohort study incorporating balance training into pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease. BMC Pulmonary Medicine. 2015;15:73. doi: 10.1186/s12890-015-0067-2.
    1. Huang SW, Wang WT, Chou LC, Chen HC, Liou TH, Lin HW. Chronic obstructive pulmonary disease increases the risk of hip fracture: a nationwide population-based cohort study. Scientific Reports. 2016;6:23360. doi: 10.1038/srep23360.
    1. Iki M, Kagamimori S, Kagawa Y, Matsuzaki T, Yoneshima H, Marumo F. Bone mineral density of the spine, hip and distal forearm in representative samples of the Japanese female population: Japanese Population-Based Osteoporosis (JPOS) Study. Osteoporosis International. 2001;12:529–537. doi: 10.1007/s001980170073.
    1. Jaramillo JD, Wilson C, Stinson DS, Lynch DA, Bowler RP, Lutz S, Bon JM, Arnold B, McDonald ML, Washko GR, Wan ES, Demeo DL, Foreman MG, Soler X, Lindsay SE, Lane NE, Genant HK, Silverman EK, Hokanson JE, Make BJ, Crapo JD, Regan EA. Reduced bone density and vertebral fractures in smokers. Men and COPD patients at increased risk. Annals of the American Thoracic Society. 2015;12:648–656. doi: 10.1513/AnnalsATS.201412-591OC.
    1. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International. 2006;17:1726–1733. doi: 10.1007/s00198-006-0172-4.
    1. Jorgensen NR, Schwarz P. Osteoporosis in chronic obstructive pulmonary disease patients. Current Opinion in Pulomnary Medicine. 2008;14:122–127. doi: 10.1097/MCP.0b013e3282f4efb6.
    1. Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease. 2008;3:637–658.
    1. Klawansky S, Komaroff E, Cavanaugh Jr PF, Mitchell DY, Gordon MJ, Connelly JE, Ross SD. Relationship between age, renal function and bone mineral density in the US population. Osteoporosis International. 2003;14:570–576. doi: 10.1007/s00198-003-1435-y.
    1. Kok VC, Horng JT, Chang WS, Hong YF, Chang TH. Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study. PLoS ONE. 2014;9:e2634. doi: 10.1371/journal.pone.0099102.
    1. Kok VC, Horng JT, Hung GD, Xu JL, Hung TW, Chen YC, Chen CL. Risk of autoimmune disease in adults with chronic insomnia requiring sleep-inducing pills: a population-based longitudinal study. Journal of General Internal Medicine. 2016;31(9):1019–1026. doi: 10.1007/s11606-016-3717-z.
    1. Kok VC, Sung FC, Kao CH, Lin CC, Tseng CH. Cancer risk in East Asian patients associated with acquired haemolytic anaemia: a nationwide population-based cohort study. BMC Cancer. 2015a;16:57. doi: 10.1186/s12885-016-2098-3.
    1. Kok VC, Tsai HJ, Su CF, Lee CK. The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population-based study. International Journal of Gynecological Cancer. 2015b;25:968–976. doi: 10.1097/IGC.0000000000000454.
    1. Kulak CA, Borba VC, Jorgetti V, Dos Reis LM, Liu XS, Kimmel DB, Kulak Jr J, Rabelo LM, Zhou H, Guo XE, Bilezikian JP, Boguszewski CL, Dempster DW. Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease. Journal of Bone and Mineral Research. 2010;25:1931–1940. doi: 10.1002/jbmr.88.
    1. Lekamwasam S, Trivedi DP, Khaw KT. An association between respiratory function and bone mineral density in women from the general community: a cross sectional study. Osteoporosis International. 2002;13:710–715. doi: 10.1007/s001980200097.
    1. Lekamwasam S, Trivedi DP, Khaw KT. An association between respiratory function and hip bone mineral density in older men: a cross-sectional study. Osteoporosis International. 2005;16:204–207. doi: 10.1007/s00198-004-1673-7.
    1. Looker AC. Relationship between femur neck bone mineral density and prevalent chronic obstructive pulmonary disease (COPD) or COPD mortality in older non-Hispanic white adults from NHANES III. Osteoporosis International. 2014;25:1043–1052. doi: 10.1007/s00198-013-2601-5.
    1. Morden NE, Sullivan SD, Bartle B, Lee TA. Skeletal health in men with chronic lung disease: rates of testing, treatment, and fractures. Osteoporosis International. 2011;22:1855–1862. doi: 10.1007/s00198-010-1423-y.
    1. Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R. Screening for osteoporosis: an update for the US Preventive Services Task Force. Annals of Internal Medicine. 2010;153:99–111. doi: 10.7326/0003-4819-153-2-201007200-00262.
    1. Nickolas TL, Leonard MB, Shane E. Chronic kidney disease and bone fracture: a growing concern. Kidney International. 2008;74:721–731. doi: 10.1038/ki.2008.264.
    1. Ogura-Tomomatsu H, Asano K, Tomomatsu K, Miyata J, Ohmori N, Kodama M, Ueda S, Takihara T, Tanaka K, Kamiishi N, Suzuki Y, Fukunaga K, Oguma T, Sayama K, Betsuyaku T. Predictors of osteoporosis and vertebral fractures in patients presenting with moderate-to-severe chronic obstructive lung disease. Copd. 2012;9:332–337. doi: 10.3109/15412555.2012.667850.
    1. Poole KE, Compston JE. Osteoporosis and its management. BMJ. 2006;333:1251–1256. doi: 10.1136/bmj.39050.597350.47.
    1. Porto EF, Castro AA, Schmidt VG, Rabelo HM, Kumpel C, Nascimento OA, Jardim JR. Postural control in chronic obstructive pulmonary disease: a systematic review. International Journal of Chronic Obstructive Pulmonary Disease. 2015;10:1233–1239. doi: 10.2147/COPD.S63955.
    1. Reid IR, Heap SW. Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Archives of Internal Medicine. 1990;150:2545–2548. doi: 10.1001/archinte.1990.00390230093012.
    1. Reyes C, Estrada P, Nogues X, Orozco P, Cooper C, Diez-Perez A, Formiga F, Gonzalez-Macias J, Prieto-Alhambra D. The impact of common co-morbidities (as measured using the Charlson index) on hip fracture risk in elderly men: a population-based cohort study. Osteoporosis International. 2014;25:1751–1758. doi: 10.1007/s00198-014-2682-9.
    1. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131:4S–42S. doi: 10.1378/chest.06-2418.
    1. Roig M, Eng JJ, MacIntyre DL, Road JD, FitzGerald JM, Burns J, Reid WD. Falls in people with chronic obstructive pulmonary disease: an observational cohort study. Respiratory Medicine. 2011;105:461–469. doi: 10.1016/j.rmed.2010.08.015.
    1. Schnell K, Weiss CO, Lee T, Krishnan JA, Leff B, Wolff JL, Boyd C. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulmonary Medicine. 2012;12:26. doi: 10.1186/1471-2466-12-26.
    1. Schuit SC, Van der Klift M, Weel AE, De Laet CE, Burger H, Seeman E, Hofman A, Uitterlinden AG, Van Leeuwen JP, Pols HA. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004;34:195–202. doi: 10.1016/j.bone.2003.10.001.
    1. Sibley KM, Voth J, Munce SE, Straus SE, Jaglal SB. Chronic disease and falls in community-dwelling Canadians over 65 years old: a population-based study exploring associations with number and pattern of chronic conditions. BMC Geriatrics. 2014;14:22. doi: 10.1186/1471-2318-14-22.
    1. Vrieze A, De Greef MH, Wijkstra PJ, Wempe JB. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporosis International. 2007;18:1197–1202. doi: 10.1007/s00198-007-0355-7.
    1. Watanabe R, Tanaka T, Aita K, Hagiya M, Homma T, Yokosuka K, Yamakawa H, Yarita T, Tai N, Hirano J, Inoue D, Okazaki R. Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. Journal of Bone and Mineral Metabolism. 2015;33:392–400. doi: 10.1007/s00774-014-0605-7.
    1. Wu XP, Liao EY, Zhang H, Dai RC, Shan PF, Cao XZ, Liu SP, Jiang Y. Determination of age-specific bone mineral density and comparison of diagnosis and prevalence of primary osteoporosis in Chinese women based on both Chinese and World Health Organization criteria. Journal of Bone and Mineral Metabolism. 2004;22:382–391. doi: 10.1007/s00774-004-0499-x.

Source: PubMed

3
S'abonner